Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S.

While many channels of the drug are being plugged regularly by authorities, the crisis is worsening - more supply routes than what can be cracked down on ...

Psilocybin shows promise for extending lifespan and slowing aging by preserving telomeres, new studies reveal.

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that is said to have the potential to end the HIV pandemic.

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

A German doctor has gone on trial in Berlin, accused of murdering 15 patients who were under palliative care. The man, who ...

He added that Fiji stands to lose over 50 percent of its current land-based economy even with just 1.5 degrees Celsius of ...